Reopening of recent laparotomy and control of intra-abdominal bleeding.
Past Medical History: Her medical history is significant for hypercholesterolemia, sleep apnea, asthma, overactive bladder, arthritis, gout, HTN, borderline hypothyroidism, obesity, and mild GERD.
Her surgical history is significant for hysterectomy in [**2178**] as well as a left knee arthroscopy in [**2183**].
She has had two pilonidal cyst operations, tonsillectomy, and adenoidectomy in the distant past.
Her GI procedures include the aforementioned ERCP and EUS and she is currently stented.
COR: RRR ABD: Subcostal and umbilical incisions with steri-strips OTA c/d/i.
Nasogastric tube is seen extending into the expected location of the stomach.
Surgical staples also noted overlying the upper left pelvis.
Right jugular line tip projects over the low SVC and a nasogastric tube passes into the stomach.
Lymph node, "Whipple," (B-C): One lymph node with no carcinoma seen.
Pancreas and duodenum, Whipple procedure (E-T): Adenocarcinoma, moderately differentiated, 2.5 cm, See Synoptic Report.
It consists of a lymph node, measuring 2.3 1.7 x 0.5 cm.
The resection margins are submitted in cassette D.  Part 4 is additionally labeled "Whipple."
It consists of a pancreaticoduodenectomy specimen that measures 12.8 x 5.2 x 4.5 cm in overall dimension.
Both proximal and distal resection margins are stapled with staple lines at each measuring 4.5 cm.
It is represented as follows: E = common bile duct margin and cystic duct, F = pancreatic parenchymal margin, G = uncinate/SMA margin, H = distal duodenal resection margin, I = proximal duodenal resection margin, J = duodenum with prominent fold,  K = ampulla, L = chronic pancreatitis, M = tumor, N = tumor in relation to posterior retroperitoneal margin, O-P = tumor, Q-R = lymph nodes submitted whole, S-T = remainder of peri-pancreatic fat.
On [**2187-8-22**], the patient underwent pylorus-preserving pancreaticoduodenectomy (Whipple), open cholecystectomy and staging laparoscopy.
She received 2units of PRBCs and her HCT improved to 31.
She arrived on the floor NPO except medications, on IV fluids, with a foley catheter and a JP drain in place, and Dilaudid PCA for pain control.
Post-operative pain was initially well controlled with the Dilaudid PCA, which was converted to oral pain medication when tolerating clear liquids.
The NG tube was discontinued on POD#3 prior to transfer to the floor, and the foley catheter discontinued at midnight of POD#4.
The patient received subcutaneous heparin and venodyne boots were used during this stay.
The patient's blood sugar was monitored regularly throughout the stay; sliding scale insulin was administered when indicated, but the patient did not require insulin for home discharge.
Medications on Admission: Protonix 40mg PO daily  Discharge Medications: 1.
Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO QID (4 times a day).
Protonix 40 mg Tablet, Delayed Release (E.C.)
Hydromorphone 2 mg Tablet Sig: 1-3 Tablets PO Q3-4 HOURS: PRN as needed for pain.
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Oxybutynin Chloride 5 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation.
Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as needed for constipation: Over-the-counter.
Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
*You may shower, and wash surgical incisions with a mild soap and warm water.
